Egypt's golf chief Omar Hisham Talaat elected to Arab Golf Federation board    Egypt extends Eni's oil and gas concession in Suez Gulf, Nile Delta to 2040    Egypt, India explore joint investments in gas, mining, petrochemicals    Egypt launches National Strategy for Rare Diseases at PHDC'25    Egyptian pound inches up against dollar in early Thursday trade    Singapore's Destiny Energy to invest $210m in Egypt to produce 100,000 tonnes of green ammonia annually    Egypt's FM discusses Gaza, Libya, Sudan at Turkey's SETA foundation    UN warns of 'systematic atrocities,' deepening humanitarian catastrophe in Sudan    Egypt's Al-Sisi ratifies new criminal procedures law after parliament amends it    Egypt launches 3rd World Conference on Population, Health and Human Development    Cowardly attacks will not weaken Pakistan's resolve to fight terrorism, says FM    Egypt's TMG 9-month profit jumps 70% on record SouthMed sales    Egypt adds trachoma elimination to health success track record: WHO    Egypt, Latvia sign healthcare MoU during PHDC'25    Egypt, India explore cooperation in high-tech pharmaceutical manufacturing, health investments    Egypt, Sudan, UN convene to ramp up humanitarian aid in Sudan    Egypt releases 2023 State of Environment Report    Egyptians vote in 1st stage of lower house of parliament elections    Grand Egyptian Museum welcomes over 12,000 visitors on seventh day    Sisi meets Russian security chief to discuss Gaza ceasefire, trade, nuclear projects    Egypt repatriates 36 smuggled ancient artefacts from the US    Grand Egyptian Museum attracts 18k visitors on first public opening day    'Royalty on the Nile': Grand Ball of Monte-Carlo comes to Cairo    VS-FILM Festival for Very Short Films Ignites El Sokhna    Egypt's cultural palaces authority launches nationwide arts and culture events    Egypt launches Red Sea Open to boost tourism, international profile    Qatar to activate Egypt investment package with Matrouh deal in days: Cabinet    Omar Hisham Talaat: Media partnership with 'On Sports' key to promoting Egyptian golf tourism    Sisi expands national support fund to include diplomats who died on duty    Madinaty Golf Club to host 104th Egyptian Open    Egypt's PM reviews efforts to remove Nile River encroachments    Al-Sisi: Cairo to host Gaza reconstruction conference in November    Egypt will never relinquish historical Nile water rights, PM says    Egypt resolves dispute between top African sports bodies ahead of 2027 African Games    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Rameda starts manufacturing of generic Anviziram for COVID-19 treatment
EDA also grants approval for Rameda to begin manufacturing intravenous Remedisivir vials
Alyaa Stohy Published in Daily News Egypt on 23 - 06 - 2020

The Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Company (Rameda) announced on Tuesday that it has started the manufacture of Anviziram.
The drug, which is the generic form of Japanese antiviral drug Avigan, contains the active pharmaceutical ingredient Favipiravir and will be used in the treatment of the novel coronavirus (COVID-19).
Avigan was developed by the Toyama Chemical Company, a subsidiary of the Japanese conglomerate Fujifilm Holdings, and contains the active ingredient Favipiravir.
The Egyptian Drug Authority (EDA) has also granted approval for Rameda to begin manufacturing of intravenous Remedisivir vials, which is also used in the treatment of coronavirus patients.
Avigan has been administered to patients with the coronavirus in clinical trials, as Favipiravir is believed to combat the virus by inhibiting viral reproduction. The trials indicate that the drug assists in stabilising viral reproduction four to six days from first use.
The Ministry of Health and Higher Education and Scientific Research have undertaken clinical trials to determine the efficacy of a range of possible treatments, including Favipiravir, on coronavirus patients.
Favipiravir has been used as experimental treatment for the virus and in clinical trials in China, Italy, Japan, and Russia. Russia's Ministry of Health has approved a generic version of the drug for use in hospitals, making Russia the first country to permit such use of Favipiravir.
"Rameda is honoured to devote its capabilities and resources to serving the Egyptian people in this unique moment," said Rameda CEO Dr Amr Morsy, "Rameda's entire production of Favipiravir is being produced under the trade name Anviziram, with capacity focused on the Egyptian market."
Morsy added that the company aims to export Anviziram to neighbouring countries upon approval from the Ministry of Health and the EDA.
In addition to Anviziram, the EDA has granted approval for Rameda to start manufacturing intravenous versions of Remedisvir, a broad-spectrum antiviral medication which has been used in coronavirus patient treatment. Rameda aims to commence production of Remdesivir in the coming period.

Clic here to read the story from its source.